Amlodipine/Olmesartan 10/40mg (Combination drug)

DRUG2 trials

Sponsors

Daewoong Pharmaceutical Co. LTD.

Conditions

HyperlipidemiasHypertensionHypertension, Dyslipidemia

Phase 3

A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia

CompletedNCT03009487

Daewoong Pharmaceutical Co. LTD.Hyperlipidemias, Hypertension

Start: 2017-01-31End: 2018-04-30Updated: 2022-01-11

Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451

Daewoong Pharmaceutical Co. LTD.Hypertension, Dyslipidemia

Start: 2019-11-20End: 2022-02-02Target: 237Updated: 2019-11-13